UA85218C2 - Crystalline form of risedronate monosodium - Google Patents

Crystalline form of risedronate monosodium

Info

Publication number
UA85218C2
UA85218C2 UAA200609599A UAA200609599A UA85218C2 UA 85218 C2 UA85218 C2 UA 85218C2 UA A200609599 A UAA200609599 A UA A200609599A UA A200609599 A UAA200609599 A UA A200609599A UA 85218 C2 UA85218 C2 UA 85218C2
Authority
UA
Ukraine
Prior art keywords
crystalline form
risedronate monosodium
risedronate
monosodium
hydroxyethylidene
Prior art date
Application number
UAA200609599A
Other languages
English (en)
Inventor
Индржих Рихтер
Йосеф Ирман
Original Assignee
Зентива А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зентива А.С. filed Critical Зентива А.С.
Publication of UA85218C2 publication Critical patent/UA85218C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Cephalosporin Compounds (AREA)
  • Steroid Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Pyridine Compounds (AREA)
UAA200609599A 2004-02-05 2005-02-04 Crystalline form of risedronate monosodium UA85218C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20040199A CZ298639B6 (cs) 2004-02-05 2004-02-05 Krystalická forma risedronátu monosodného

Publications (1)

Publication Number Publication Date
UA85218C2 true UA85218C2 (en) 2009-01-12

Family

ID=34832121

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200609599A UA85218C2 (en) 2004-02-05 2005-02-04 Crystalline form of risedronate monosodium

Country Status (8)

Country Link
EP (1) EP1711507B1 (ru)
AT (1) ATE416182T1 (ru)
CZ (1) CZ298639B6 (ru)
DE (1) DE602005011401D1 (ru)
EA (1) EA008494B1 (ru)
PL (2) PL380526A1 (ru)
UA (1) UA85218C2 (ru)
WO (1) WO2005075487A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83900C2 (en) 2004-02-26 2008-08-26 ЗЕНТИВА, а.с. Amorphous forms of risedronate monosodium
WO2007042048A2 (en) * 2005-10-11 2007-04-19 Sandoz A/S Method for preparing crystalline sodium risedronate
US8076483B2 (en) 2006-05-11 2011-12-13 M/S. Ind Swift Laboratories Limited Process for the preparation of pure risedronic acid or salts
DE102007030370A1 (de) 2007-06-29 2009-01-02 Ratiopharm Gmbh Essigsäure-Solvate von Risedronat, Polymorph hiervon, deren Herstellung und Verwendung sowie pharmazeutische Zusammensetzung, enthaltend diese

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728805B1 (fr) * 1994-12-29 1997-03-28 Total Raffinage Distribution Procede et dispositif pour le strippage de solides fluidises et utilisation dans un procede de craquage a l'etat fluide
PE20011061A1 (es) * 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
PL372964A1 (en) * 2002-04-11 2005-08-08 Teva Pharmaceutical Indudstries, Ltd. Novel polymorphs and pseudopolymorphs of risedronate sodium

Also Published As

Publication number Publication date
EP1711507B1 (en) 2008-12-03
EP1711507A1 (en) 2006-10-18
DE602005011401D1 (de) 2009-01-15
CZ2004199A3 (cs) 2005-09-14
WO2005075487A1 (en) 2005-08-18
PL380526A1 (pl) 2007-02-19
EA200601366A1 (ru) 2006-12-29
EA008494B1 (ru) 2007-06-29
CZ298639B6 (cs) 2007-12-05
PL1711507T3 (pl) 2009-06-30
ATE416182T1 (de) 2008-12-15

Similar Documents

Publication Publication Date Title
RS52274B (en) UNIT DIARYLHIDANTOIN
PT3059208T (pt) Fosfato de cálcio cristalino de tamanho nanométrico sintético
ZA200205090B (en) Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate.
AU2006304874A8 (en) Pyrimidinones as casein kinase II (CK2) modulators
AU2003300898A1 (en) Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
UA93531C2 (en) Novel hydrogen sulfate salt
IL162734A0 (en) Phosphorus-containing compounds & uses thereof
GEP20104895B (en) Preparation of pregabalin and related compounds
WO2006055329A3 (en) Dental fillers including a phosphorus-containing surface treatment
ATE493413T1 (de) Wasserfreie kristalline formen von n-ä1,2- ethoxyethyl)-5-(n-ethyl-n-methylaminoü-7-(4- methylpyridin-2-yl-aminoü-1h-pyrazoloä4,3-
DE602005014936D1 (en) Phosphoramidatderivate
ATE516291T1 (de) Thenopyrimidin-verbindungen mit fungizider aktivität
TW200800956A (en) 2-Aminopyrimidine derivatives
RS53599B1 (en) PIRIDON DERIVATIVES FOR STRESS MODULATION OF ACTIVATED PROTEIN KINASE SYSTEMS
IS7453A (is) Trópan afleiður sem CCR5 stillar
WO2007023342A3 (en) Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof
UA83900C2 (en) Amorphous forms of risedronate monosodium
UA85218C2 (en) Crystalline form of risedronate monosodium
EP1845780A4 (en) USES OF METHYLPHENIDATE DERIVATIVES
CA2346171A1 (en) Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid
TW200724168A (en) Pharmaceutical compositions
AU2003210225A1 (en) Phosphorus chelate compounds
MXPA05006957A (es) Nuevos derivados de fosforamida.
EP1613606A4 (en) PROCESS FOR PREPARING 2,3,5,6-SUBSTITUTED 3H-PYRIMIDIN-4-ONES
ZA200301297B (en) Control of encrustations of phosphate-containing double salts.